🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the safety and efficacy ...
Status
Completed
Location
UCI Center for Clinical Research
Start Date
2021-06-28
Trial ID
NCT04886518
Treatments Being Tested
Primary objective was to evaluate the effects of dronedarone on Atrial Fibr...
Status
Terminated
Location
Investigational Site Number 840015
Start Date
2010-07
Trial ID
NCT01135017
Treatments Being Tested
GSK2798745 is a potent and selective transient receptor potential vanilloid...
Status
Terminated
Location
GSK Investigational Site
Start Date
2018-04-05
Trial ID
NCT03372603
Treatments Being Tested
The primary objective of this trial is to assess the effects of cytisinicli...
Status
Completed
Location
BlueClinical Phase I
Start Date
2022-10-17
Trial ID
NCT05566288
Treatments Being Tested
The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-01-12
Trial ID
NCT03004404
This is a first exploration of GLPG3970 in subjects with active systemic lu...
Status
Terminated
Location
Medical center Medconsult Pleven
Start Date
2020-12-28
Trial ID
NCT04700267
Treatments Being Tested
The study will investigate whether administration of clazosentan can affect...
Status
Completed
Location
QPS Netherlands B.V.
Start Date
2018-09-18
Trial ID
NCT03657446
Treatments Being Tested
Combination therapy in pulmonary arterial hypertension (PAH) has been the s...
Status
Completed
Location
Providence Medical Foundation
Start Date
2019-07-29
Trial ID
NCT03904693
The main objective of this trail is to investigate if and to what extent BI...
Status
Completed
Location
Collaborative Neuroscience Research, LLC
Start Date
2020-12-01
Trial ID
NCT04602221
Treatments Being Tested
The main objective is to determine whether a low-dose regimen of apixaban (...
Status
Completed
Location
Medical university of Graz
Start Date
2018-10-11
Trial ID
NCT03692065
Treatments Being Tested